Cover Image
QR Code

Putting Viral Clearance Capabilities to the Test: Process understanding and careful assessment of risks are essential in developing viral clearance programs.

Published in:BioPharm International Vol. 31; no. 5; pp. 18 - 21
Main Author: Peters, Rita
Format: Journal Article
Published: MJH Life Sciences May2018
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129525417&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 129525417
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: May2018
      vid: 31
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        129525417
        129525417
      ppf: 18
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Putting Viral Clearance Capabilities to the Test: Process understanding and careful assessment of risks are essential in developing viral clearance programs.
      aug:
        au: Peters, Rita
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N